Abbas Ardehali
Direktor/Vorstandsmitglied bei BIOM'UP
Aktive Positionen von Abbas Ardehali
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BIOM'UP | Direktor/Vorstandsmitglied | 30.01.2018 | - |
Medcura, Inc.
 Medcura, Inc. Medical SpecialtiesHealth Technology Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD. | Direktor/Vorstandsmitglied | 01.06.2023 | - |
Karriereverlauf von Abbas Ardehali
Ausbildung von Abbas Ardehali
| Emory University School of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Frankreich | 2 |
Operativ
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Biom'Up SA
 Biom'Up SA Medical SpecialtiesHealth Technology Biom'Up SA engages in the development of hemostatic product composed of patent-protected biopolymers. Its products include Hemoblast Bellows and Hemosnow. The company was founded by Patricia Forest, Sylvain Picot and Christian Gagnieu on February 21, 2005 and is headquartered in Lyon, France. | Health Technology |
Medcura, Inc.
Medcura, Inc. Medical SpecialtiesHealth Technology Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD. | Health Technology |
- Börse
- Insiders
- Abbas Ardehali
- Erfahrung
